PREVENTION AND MANAGEMENT OF PATIENTS WITH CARDIO- RENAL-METABOLIC COMORBIDITIES

Objectives

• Discuss the pathophysiologic relations between metabolic conditions, cardio, and renal associated diseases.
• Identify risk reduction strategies to prevent cardio-renal-metabolic comorbidities.
• Discuss evidence-based data that support the use of medications to prevent cardio-renal -metabolic comorbidities.
• Describe place in therapy of the different pharmacologic interventions to prevent and manage metabolic-cardio-renal comorbidities. 
• Analyze the differences in incretin-based, sodium-glucose cotransporter 2 inhibitors and other therapies related to cardiorenal protection
• Explain risks and benefits of medications in people with diabetes, heart failure and/or chronic kidney disease to prevent or manage comorbidities.
• Value the role of the pharmacist as member of interprofessional team caring for these patients.

Activity Number

0151-0000-24-014-L01-P

CE Hours